Hepatitis C Virus Translation Inhibitors Targeting the Internal Ribosomal Entry Site

Citations Over TimeTop 10% of 2013 papers

Abstract

The internal ribosome entry site (IRES) in the 5' untranslated region (UTR) of the hepatitis C virus (HCV) genome initiates translation of the viral polyprotein precursor. The unique structure and high sequence conservation of the 5' UTR render the IRES RNA a potential target for the development of selective viral translation inhibitors. Here, we provide an overview of approaches to block HCV IRES function by nucleic acid, peptide, and small molecule ligands. Emphasis will be given to the IRES subdomain IIa, which currently is the most advanced target for small molecule inhibitors of HCV translation. The subdomain IIa behaves as an RNA conformational switch. Selective ligands act as translation inhibitors by locking the conformation of the RNA switch. We review synthetic procedures for inhibitors as well as structural and functional studies of the subdomain IIa target and its ligand complexes.

Related Papers

• → Influence of the hepatitis C virus 3′‐untranslated region on IRES‐dependent and cap‐dependent translation initiation(2010)48 cited
• → An atypical IRES within the 5′ UTR of a dicistrovirus genome(2008)36 cited
• → Translation efficiencies of the 5' untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system.(1998)73 cited
• → A Single Nucleotide Insertion in the 5′-Untranslated Region of Hepatitis C Virus Leads to Enhanced Cap-Independent Translation(1999)27 cited
• → Structural Elements in the 5′-Untranslated Region of Giardiavirus Transcript Essential for Internal Ribosome Entry Site-Mediated Translation Initiation(2005)20 cited